Stemedix joins in Collaboration with the University of South Florida
Stemedix, Inc. is excited to announce their research collaboration agreement with the University of South Florida in efforts to advance regenerative medicine offerings with a more precise and personalized approach.
This agreement will allow Stemedix, Inc. and the University of South Florida to work together in efforts to improve patient outcomes. Our partnership will also help Stemedix deeper understand how current umbilical cord tissue products perform to improve cell activity in the regenerative and healing process. Our goal is to perform research that will create enhanced targeted protocols that can be used under an IND (investigational new drug) in order to achieve FDA approval. “We are more than excited to be a big part of advancing the field of Regenerative Medicine in hopes to creating the next round of achievements for better patient outcomes. The ground work we are doing today will create more robust targeted therapies to present to the FDA for approval.” Said Fred Palmer- Director of Operations at Stemedix.
Stemedix, Inc. is proud to be partnering with this prestigious university to bring about exciting opportunities in the field of Regenerative Medicine and for many patients seeking an alternative option that will address their needs personally.